The FDA recently approved SEDASYS, a new robotic device which can automate the sedation of healthy patients having colonoscopies. Ethicon Endo-Surgery, a Johnson & Johnson subsidiary, created SEDASYS, a computer-assisted device that administers the prescription drug propofol into the bloodstream via intravenous IV infusion. The device can detect signs associated with oversedation and can automatically modify or stop infusion.
“The technology will empower healthcare facilities to more effectively use their limited resources to deliver greater value in the increasingly resource-constrained U.S. healthcare environment.” SEDASYS will cost about $150 per procedure – on a fee-per-use plan from J&J – where anesthesiologists generally cost between $600 to $2,000.
Actively lobbied against for years by the anesthesiologists association, the FDA finally approved the device in May. J&J will begin marketing SEDASYS early next year.